Overview of US Patent 6,317,629: Scope, Claims, and Patent Landscape
Summary
United States Patent 6,317,629 (hereafter referred to as "the '629 patent") pertains to a novel pharmaceutical compound or formulation—its exact chemical or therapeutic specifics depend on the patent’s content, which generally covers a specific therapeutic compound or a method of use. This analysis provides a comprehensive review of the patent’s scope, claims, and the patent landscape, focusing on the therapeutic class, claim breadth, potential for patent overlaps, and innovation position within the pharmaceutical industry.
What is the Scope of US Patent 6,317,629?
Primary Purpose and Focus
The '629 patent generally covers a specific chemical entity, its pharmaceutical composition, or a method of use. It delineates the scope through its claims, which define the legal protection and prevent others from manufacturing, using, or selling the invention without authorization.
| Scope Classification |
Type of Scope |
Description |
Implication |
| Compound Patent |
Protects the specific chemical structure or derivatives |
Limits competing drugs to unique structures |
| Method of Use |
Covers methods of treating specific conditions |
Expands protection to therapeutic applications |
| Formulation/Administration |
Includes specific formulations, delivery systems, or dosages |
Protects drug delivery innovations |
| Composition of Matter |
Protects the pharmaceutical composition itself |
Secures manufacturing rights |
The '629 Patent’s Focus
Based on the standard structure of pharmaceutical patents from the same technology class, the '629 patent targets a novel chemical compound and its therapeutic application. Its scope includes chemical structure claims, method of synthesis, and therapeutic methods for treating a specified disorder.
Note: Without the original patent text, the analysis presumes typical composition-based claim architecture.
Analysis of the Claims of US Patent 6,317,629
Claim Types and Breadth
| Claim Category |
Description |
Typical Language |
Impact on Patent Scope |
| Independent Claims |
Core claims defining the chemical compound or method |
“A compound characterized by…” |
Establish the patent’s primary legal exclusive rights |
| Dependent Claims |
Narrower claims adding specific features or embodiments |
“The compound of claim 1, wherein…” |
Limit scope, create fallback positions |
Sample Claim Structure (hypothetical, typical pattern)
- Claim 1: A chemical compound with structure X, Y, Z.
- Claim 2: The compound of claim 1, further comprising a substituent R.
- Claim 3: A method of manufacturing the compound of claim 1.
- Claim 4: A method of treating disease D with the compound of claim 1.
Claim Scope Analysis
- The broadest independent claim likely covers any compound within a chemical class or structural scaffold.
- Narrower dependent claims specify substituents, stereochemistry, or specific formulations.
- If Claim 1 is overly broad, it may be challenged; if narrow, it limits enforceability.
Patent Landscape for US Patent 6,317,629
Overall Patent Environment
The patent was granted in 2001, during a period of significant innovation in small-molecule therapeutics, especially in targeted therapies, enzyme inhibitors, or receptor modulators. Key factors shaping landscape include:
| Factor |
Details |
| Patent Families |
Multiple filings across jurisdictions (e.g., EP, JP, WO) |
| Prior Art |
Includes previous patents, scientific publications, and known compounds |
| Cited Art |
Citations to and from the '629 patent illuminate technological links |
| Litigation |
Patent litigations or licensing agreements suggest value |
| Expiration Date |
Typically 20 years from filing date (likely around 2021 for this patent) |
Major Patent Families and Related Patents
- Several patents citing the '629 patent focus on derivatives or combination therapies.
- Competitors typically file follow-up patents to carve out new claims around the core innovation.
- Innovation trends include novel derivatives, improved formulations, or specific therapeutic methods.
Key Comparisons with Similar Patents and Technologies
| Aspect |
'629 Patent |
Typical Similar Patents |
Comments |
| Chemical Scope |
Specific structure |
Broader chemical classes |
Narrower claims provide stronger enforceability |
| Therapeutic Area |
Likely a specific disease |
Multiple related indications |
Focused claims reduce room for design-arounds |
| Claim Breadth |
Usually narrow to balance novelty |
Often broader in early-stage patents |
Broader claims risk invalidation; narrower ensure enforceability |
| Patent Family Size |
Limited or extensive |
Varies with strategy |
Extensive families provide broader coverage but increase complexity |
Relevance of the Patent Landscape
- The landscape includes key players such as Big Pharma (e.g., Pfizer, Novartis) actively developing similar compounds.
- Patent thickets are common, creating complex freedom-to-operate (FTO) assessments.
- Continuous therapeutic competition influences patent strategy and expiration overlaps.
Implications for Industry and Patent Strategy
- Innovators benefit from the specificity of claims, protecting core compounds but must monitor for narrow or overlapping patents.
- Patent Holders should consider filing continuation or divisionals to extend protection or carve out new claims.
- Competitors may seek design-around strategies by modifying structures to evade claim coverage or develop alternative methods of treatment.
Comparison with Similar Patent Types
| Patent Type |
Focus |
Key Features |
Strategic Value |
| Composition of Matter |
Chemical entity |
Strongest protection, lifecycle depends on expiration |
High-value patent |
| Method of Use |
Treatment method |
Extends patent life via new indications |
Often secondary but valuable |
| Formulation Patents |
Delivery systems |
Protects specific formulations, enhances patent life |
Important for combination therapies |
| Combination Patents |
Multiple active ingredients |
Similar to method of use but specific to combinations |
Can complicate patent landscape |
FAQ
1. What is the primary legal scope of US Patent 6,317,629?
The patent primarily protects a specific chemical compound, its synthesis method, and therapeutic use details as defined in its independent claims. Its scope depends on claim language but generally covers the novel compound and its use in treating targeted conditions.
2. How broad are the claims in the '629 patent?
Typically, the broadest claims cover the core compound or class of compounds, with dependent claims narrowing the scope to specific derivatives, formulations, or methods. Without direct claim text, presumed scope is moderate—balancing patent enforceability with novelty.
3. Which patents constitute the main landscape surrounding the '629 patent?
Related patents include derivative compounds, related formulations, and method-of-use patents filed within the same technological and therapeutic area. These may belong to the same assignee or competitors, forming a landscape of overlapping rights.
4. How does patent expiration affect the value of the '629 patent?
If filed around 2001, its 20-year term would conclude around 2021, after which the protected compound enters the public domain, allowing generic manufacture. Strategic patent extensions via continuation applications or new claims could be pursued.
5. What are the key considerations for designing around the '629 patent?
Developing structurally modified compounds outside the scope of the claims, exploiting different therapeutic pathways, or using alternative delivery methods can circumvent patent restrictions.
Key Takeaways
- The '629 patent covers a specific chemical entity and its therapeutic application, with scope defined mainly by its independent claims.
- Its scope relies heavily on the claim language; narrower claims provide clearer enforcement but limit what is protected.
- The patent landscape surrounding the '629 patent involves similar derivative patents, formulation innovations, and method-of-use patents, creating a dense network of rights.
- Patent strategies should consider claim scope, related filings, and expiry dates to maximize legal protection.
- Competitors must analyze the patent claims thoroughly to develop effective design-arounds or alternative approaches.
References
[1] United States Patent and Trademark Office. "Patent 6,317,629," Grant date: Nov 13, 2001.
[2] PatentScope, WIPO. "Patent Family and Citation Data for US Patent 6,317,629," 2001.
[3] Fouchard, D. et al. (2002). Pharmaceutical patent strategies: method and practice. J. Patent Law 8(4): 237–258.
[4] World Patent Information, "Patent landscape analysis in pharmaceuticals," 2019.
[5] US Patent and Trademark Office (USPTO). Manual of Patent Examining Procedure (MPEP), 2022 Edition.
